Skip to content

Immunocore Holdings plc

IMCR

CIK 0001671927

← back to feed
Revenue (TTM)
$402.22M
+29.0% YoY Q1 Apr 2026
Net Income (TTM)
$7.52M
+30.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.15
+30.4% YoY Q1 Apr 2026
Gross Margin
99.3%
Q1 Apr 2026
Operating Margin
-4.6%
Q1 Apr 2026
Net Margin
1.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$12.9M
Q1 Apr 2026
Cash
$452.68M
Q1 Apr 2026
Total Debt
$438.7M
Q1 Apr 2026
Shares Outstanding
50.87M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings